An analog of the gut hormone glucagon-like peptide 1 (GLP-1) has recently been approved for use in weight management, demonstrating the value of appropriating endogenous systems for the treatment of obesity (5). Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.